BeStock  
Stocks › Biotechnology › NRIX

Nurix Therapeutics NRIX

US equityMarket cap rank #2921Biotechnology
$12.85 −$0.75 (-5.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.85 0.00%
Open$13.40
Prev close$13.60
Day range$12.83 – $13.67
Volume2.43M
Market cap$1.40B
P/E (TTM)5.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership108.9%-6.84 pts vs. prior quarter
Institutions holding258+6 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
ARK fund activity+350,410 sh1 recent transactions · last 3 Nov 2026
Short interest17.33% of floatDays to cover 7.2 · as of 30 Oct 2026
Short-sale volume share16.0%5-day average of daily volume

Short-sale volume as % of daily volume

3%12%21%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.96M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$2.4MSuper+$546.8KBig+$1.6MMid+$16.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 34.2% of shares outstanding.

Largest holders

  • BlackRock8.06%
  • Vestal Point Capital, LP7.37%
  • Deep Track Capital, LP7.08%
  • Rubric Capital Management LP6.62%
  • Perceptive Advisors LLC5.07%
  • T. Rowe Price Group, Inc.4.98%
  • Morgan Stanley4.80%
  • FMR4.28%

By investor type

  • Mutual Fund50.87%
  • Hedge Fund32.58%
  • VC/PE Fund15.66%
  • Public Company7.73%
  • Private Company1.10%
  • Individual/Insider0.89%
  • Insurance Company0.47%
  • Government Pension Fund0.21%

Reported short interest has held roughly steady near 17.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +484,027 4.8%
JPMorgan Chase & Co. Public Company 2026/Q3 +320,853 0.3%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +318,517 0.5%
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +216,994 0.3%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +207,694 0.3%
Barclays PLC Public Company 2026/Q3 +161,968 0.2%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +1,216,207 5.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +195,787 0.5%
Rubric Capital Management LP Hedge Fund 2026/Q3 +4,753,893 6.6%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +2,146,354 5.0%
Vestal Point Capital, LP Hedge Fund 2026/Q3 +1,550,000 7.4%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +1,391,211 7.1%
Capital Research Mutual Fund 2026/Q3 +894,589 1.6%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +650,621 1.3%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +527,000 1.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Nov 2026 Johannes Van Houte Chief Financial Officer Automatic Disposition -4,769 $16.20 42,745
2 Nov 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Intent to Sell (Form 144) -6,113 $25.70 –
2 Nov 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Automatic Disposition -10,929 $26.76 4,406
1 Nov 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Derivative Exercise and Sale -5,786 $25.74 4,406
1 Nov 2026 Gwenn Hansen Chief Scientific Officer Derivative Exercise and Sale -1,452 $26.80 123,452
29 Oct 2026 Johannes Van Houte Chief Financial Officer Derivative Exercise and Sale -2,834 $26.28 47,514
29 Oct 2026 Johannes Van Houte Chief Financial Officer Derivative Exercise and Retained +7,348 – 47,514
29 Oct 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Derivative Exercise and Sale -3,957 $26.28 15,335
29 Oct 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Derivative Exercise and Retained +6,225 – 15,335
29 Oct 2026 Gwenn Hansen Chief Scientific Officer Open Market Disposition -3,957 $26.28 123,452
29 Oct 2026 Gwenn Hansen Chief Scientific Officer Derivative Exercise and Retained +10,182 – 123,452
14 Oct 2026 Gwenn Hansen Chief Scientific Officer Derivative Exercise and Sale -1,452 $25.00 117,227
13 Oct 2026 Julia Gregory Independent Chairperson Derivative Exercise and Sale -22,583 $23.40 10,750
1 Oct 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Derivative Exercise and Sale -5,786 $23.19 9,110
1 Sep 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Derivative Exercise and Sale -5,787 $26.64 9,110
31 Aug 2026 Gwenn Hansen Chief Scientific Officer Derivative Exercise and Sale -1,452 $25.47 117,227
4 Aug 2026 Gwenn Hansen Chief Scientific Officer Derivative Exercise and Sale -4,356 $25.00 117,227
3 Aug 2026 Johannes Van Houte Chief Financial Officer Automatic Disposition -4,761 $24.65 40,166
3 Aug 2026 Gwenn Hansen Chief Scientific Officer Automatic Disposition -4,111 $24.64 117,227
2 Aug 2026 Christine Ring Chief Legal Officer, Secretary & Chief Compliance Officer Automatic Disposition -10,802 $23.05 9,110

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 18,936,583 17.3% 7.2
15 Oct 2026 20,607,897 18.9% 9.2
30 Sep 2026 17,657,588 17.0% 9.9
15 Sep 2026 17,976,804 17.3% 14.1
31 Aug 2026 17,950,461 17.3% 15.9
14 Aug 2026 17,984,342 17.3% 18.1

Discussion

No comments yet — be the first to weigh in on NRIX.

Sign in to join the discussion.

Scroll to Top